56 filings
8-K
IVVD
Invivyd Inc
22 May 24
Invivyd Elects Two New Independent Members to its Board of Directors
7:06am
8-K
IVVD
Invivyd Inc
9 May 24
Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:08pm
8-K
IVVD
Invivyd Inc
7 May 24
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19
7:38am
8-K
IVVD
Invivyd Inc
12 Apr 24
Invivyd Announces CEO Transition
7:36am
8-K
IVVD
Invivyd Inc
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
8-K
8bxygrf1gvhpytnmpnf
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
8-K
v8b1cv
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDAâ„¢ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
eq2bv
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
b0hhe3s0ex0qutb3l6c
8 Jan 24
Other Events
7:12am
8-K
kvdi1z3snp64kukdi7hv
3 Jan 24
Other Events
7:06am
8-K
fol scj323rpqrybo
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
8-K
ttxj8
18 Dec 23
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial
7:16am
8-K
i4418bn4g0
9 Nov 23
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
4:10pm
8-K
mdpnixyl2ekfxju
11 Sep 23
Other Events
7:10am
8-K
h9alxje87qeiqvlg
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am
8-K
m35tnwb
10 Aug 23
Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
f5fk0
27 Jul 23
Invivyd Announces Appointment of Sara Cotter to Board of Directors
4:06pm
8-K
5ja2nz4oknwwdjzu
29 Jun 23
Other Events
7:08am
8-K
sarqq8 77
25 May 23
Amendments to Articles of Incorporation or Bylaws
4:20pm
8-K
nrwbsc1lz4g
11 May 23
Invivyd Reports First Quarter 2023 Financial Results and Business Highlights
4:08pm